细胞讯号传导市场 - 全球产业规模、份额、趋势、机会和预测，按类型、产品、技术、途径、地区和竞争细分，2020-2030 年预测

2024 年全球细胞讯号传导市场价值为 56.2 亿美元，预计到 2030 年将达到 88.7 亿美元，预测期内复合年增长率为 7.87%。全球细胞讯号传导市场主要受到慢性病盛行率不断上升、分子生物学进步以及个人化医疗需求不断增长的推动。细胞讯号传导在调节生长、分化和免疫反应等关键细胞过程中发挥至关重要的作用，这使其在疾病机制（特别是癌症、糖尿病和神经系统疾病）中至关重要。由于细胞讯号通路对于确定新的治疗标靶至关重要，药物研发的兴起和标靶治疗的需求进一步推动了市场的发展。高通量筛选、生物标记和诊断工具的技术进步正在提高细胞讯号传导研究的效率。医疗保健和生命科学研究方面不断增长的投资也为市场扩张做出了巨大贡献。

主要市场驱动因素

慢性病和癌症发生率不断上升

主要市场挑战

细胞讯号路径的复杂性

主要市场趋势

增加生物技术领域的公共和私人资金

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球细胞讯号市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（内分泌讯号、旁分泌讯号、自分泌讯号及其他）
  • 按产品（消耗品和仪器）
  • 按技术（流式细胞仪、显微镜检查、蛋白质印迹法、ELISA 等）
  • 按通路（AKT 讯息传递路径、AMPK 讯息传递路径、ErbB/HER 讯息传递路径等）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美细胞讯号市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲细胞讯号市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区细胞讯号市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲细胞讯号市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲细胞讯号市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Thermo Fisher Scientific, Inc.
• QIAGEN NV
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cell Signaling Technology, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Promega Corporation

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Cell Signaling Market was valued at USD 5.62 Billion in 2024 and is expected to reach USD 8.87 Billion by 2030 with a CAGR of 7.87% during the forecast period. The Global Cell Signaling Market is primarily driven by the increasing prevalence of chronic diseases, advancements in molecular biology, and the growing demand for personalized medicine. Cell signaling plays a crucial role in regulating key cellular processes such as growth, differentiation, and immune response, making it vital in disease mechanisms, particularly cancer, diabetes, and neurological disorders. The rise in drug discovery and the need for targeted therapies are further propelling the market, as cell signaling pathways are pivotal in identifying new therapeutic targets. Technological advancements in high-throughput screening, biomarkers, and diagnostic tools are enhancing the efficiency of cell signaling research. Growing investments in healthcare and life sciences research also contribute significantly to market expansion.

Key Market Drivers

Increasing Prevalence of Chronic Diseases and Cancer

Chronic diseases, including cancer, cardiovascular diseases, diabetes, and neurological disorders, have become a major public health concern worldwide. Cancer alone has led to an exponential increase in demand for targeted therapies that specifically influence cell signaling pathways. Cell signaling mechanisms are crucial in both the initiation and progression of cancer. As cancer cells exploit these pathways to grow uncontrollably, therapies targeting these signaling mechanisms are rapidly being developed. According to WHO, in 2021, noncommunicable diseases (NCDs) were responsible for at least 43 million deaths, accounting for 75% of all non-pandemic-related deaths globally. Among these, 18 million individuals died from an NCD before reaching 70 years of age, with 82% of these premature deaths occurring in low- and middle-income countries. Overall, 73% of all NCD-related deaths took place in these regions. Cardiovascular diseases were the leading cause, responsible for at least 19 million deaths in 2021, followed by cancers (10 million), chronic respiratory diseases (4 million), and diabetes (over 2 million, including kidney disease deaths related to diabetes). Together, these four disease categories contribute to 80% of all premature NCD deaths. Risk factors such as tobacco use, physical inactivity, excessive alcohol consumption, unhealthy diets, and air pollution significantly increase the likelihood of dying from an NCD.

Key Market Challenges

Complexity of Cell Signaling Pathways

Cell signaling pathways are highly complex and involve numerous molecules, receptors, enzymes, and transcription factors that interact with each other in a precise and sometimes unpredictable manner. This complexity makes understanding the exact mechanisms behind cellular responses to stimuli challenging. Researchers are often confronted with difficulties in fully mapping out the networks of signaling pathways in different cell types and under varying physiological conditions. There is a lack of comprehensive tools and technologies capable of capturing all the intricacies of these networks. This complexity can delay the identification of key therapeutic targets and make drug discovery more difficult, particularly in diseases with dysregulated signaling. Targeting specific pathways without unintended consequences to other cellular processes is a major concern, increasing the risk of off-target effects. As a result, this complexity can slow the development of effective treatments based on cell signaling and hinder the overall market growth.

Key Market Trends

Increasing Public and Private Funding in Biotechnology

The biotechnology sector is witnessing a significant surge in public and private funding, which directly impacts the cell signaling market. Governments worldwide are investing in healthcare innovation through grants, subsidies, and tax incentives for biotechnology companies that focus on molecular and cellular therapies. Private sector investment, particularly from venture capital firms, is also growing as investors recognize the potential of cell signaling as a therapeutic target. These investments not only support basic research but also stimulate the development of new drug candidates, biologics, and diagnostic tools that leverage knowledge of cell signaling pathways. The increased funding enables the development of cutting-edge research centers and the commercialization of novel products, accelerating market growth.

Key Market Players

• Thermo Fisher Scientific, Inc.
• QIAGEN N.V.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cell Signaling Technology, Inc.
• Danaher Corporation
• Merck KGaA
• PerkinElmer, Inc.
• Promega Corporation

Report Scope:

In this report, the Global Cell Signaling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Signaling Market, By Type:

• Endocrine Signaling
• Paracrine Signaling
• Autocrine Signaling
• Others

Cell Signaling Market, By Product:

• Consumables
• Instruments

Cell Signaling Market, By Technology:

• Flow Cytometry
• Microscopy
• Western Blotting
• ELISA
• Others

Cell Signaling Market, By Pathway:

• AKT Signaling Pathway
• AMPK Signaling Pathway
• ErbB/HER Signaling Pathway
• Others

Cell Signaling Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Signaling Market.

Available Customizations:

Global Cell Signaling market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Signaling Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, and Others)
  • 5.2.2. By Product (Consumables and Instruments)
  • 5.2.3. By Technology (Flow Cytometry, Microscopy, Western Blotting, ELISA, and Others)
  • 5.2.4. By Pathway (AKT Signaling Pathway, AMPK Signaling Pathway, ErbB/HER Signaling Pathway, and Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Cell Signaling Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product
  • 6.2.3. By Technology
  • 6.2.4. By Pathway
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Signaling Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technology
      • 6.3.1.2.4. By Pathway
  • 6.3.2. Canada Cell Signaling Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technology
      • 6.3.2.2.4. By Pathway
  • 6.3.3. Mexico Cell Signaling Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technology
      • 6.3.3.2.4. By Pathway

7. Europe Cell Signaling Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product
  • 7.2.3. By Technology
  • 7.2.4. By Pathway
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell Signaling Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technology
      • 7.3.1.2.4. By Pathway
  • 7.3.2. United Kingdom Cell Signaling Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technology
      • 7.3.2.2.4. By Pathway
  • 7.3.3. Italy Cell Signaling Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technology
      • 7.3.3.2.4. By Pathway
  • 7.3.4. France Cell Signaling Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technology
      • 7.3.4.2.4. By Pathway
  • 7.3.5. Spain Cell Signaling Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technology
      • 7.3.5.2.4. By Pathway

8. Asia-Pacific Cell Signaling Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product
  • 8.2.3. By Technology
  • 8.2.4. By Pathway
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell Signaling Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technology
      • 8.3.1.2.4. By Pathway
  • 8.3.2. India Cell Signaling Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technology
      • 8.3.2.2.4. By Pathway
  • 8.3.3. Japan Cell Signaling Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technology
      • 8.3.3.2.4. By Pathway
  • 8.3.4. South Korea Cell Signaling Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Technology
      • 8.3.4.2.4. By Pathway
  • 8.3.5. Australia Cell Signaling Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Technology
      • 8.3.5.2.4. By Pathway

9. South America Cell Signaling Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product
  • 9.2.3. By Technology
  • 9.2.4. By Pathway
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Signaling Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technology
      • 9.3.1.2.4. By Pathway
  • 9.3.2. Argentina Cell Signaling Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technology
      • 9.3.2.2.4. By Pathway
  • 9.3.3. Colombia Cell Signaling Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technology
      • 9.3.3.2.4. By Pathway

10. Middle East and Africa Cell Signaling Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Pathway
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Signaling Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technology
      • 10.3.1.2.4. By Pathway
  • 10.3.2. Saudi Arabia Cell Signaling Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technology
      • 10.3.2.2.4. By Pathway
  • 10.3.3. UAE Cell Signaling Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technology
      • 10.3.3.2.4. By Pathway

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. QIAGEN N.V.
• 14.3. Becton, Dickinson and Company
• 14.4. Bio-Rad Laboratories, Inc.
• 14.5. Bio-Techne Corporation
• 14.6. Cell Signaling Technology, Inc.
• 14.7. Danaher Corporation
• 14.8. Merck KGaA
• 14.9. PerkinElmer, Inc.
• 14.10. Promega Corporation

15. Strategic Recommendations

16. About Us & Disclaimer